| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $71.3M | -18.8% |
| SG&A Expense | $28.5M | -10.6% |
| Operating Income | -$99.8M | +16.6% |
| Pre-tax Income | -$75.8M | +27.3% |
| Income Tax | $0 | — |
| Net Income | -$75.8M | +27.3% |
| EPS (Basic) | -$0.35 | +27.1% |
| EPS (Diluted) | -$0.35 | +27.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.6M | -57.8% |
| Short-term Investments | $568.6M | +1.5% |
| Current Assets | $616.4M | -7.6% |
| Total Assets | $621.5M | -7.5% |
| Current Liabilities | $14.0M | +6.2% |
| Total Liabilities | $16.4M | -4.1% |
| Stockholders' Equity | $605.1M | -7.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.0M | +29.2% |
| Investing Cash Flow | $8.9M | -85.9% |
| Financing Cash Flow | $628K | -52.7% |